Acquisition strengthens Lipid Nutrition’s position in global CLA market
Wormerveer, Netherlands, January 26, 2006 – Lipid Nutrition, division of IOI-Loders
Croklaan Group B.V., has signed an agreement to acquire PharmaNutrients’ CLA One®
business effective February 1, 2006. As a result of this acquisition, Lipid Nutrition
substantially reinforces its position as a dominant player in the CLA market.
PharmaNutrients has elected to divest of its CLA One® product line to focus on its business
of proprietary nutritional formulations targeting inflammation, diabetes and cardiovascular
“I am confident that our clients will get the support, knowledge and expertise they need to
continue in their success,” stated Mark Nottoli, President of PharmaNutrients. “Handing over
our CLA One® business to Lipid Nutrition, a bigger company with the same philosophy and
more expertise, is the best thing for our clients. This provides us the opportunity to focus on
our other specialty products.”
Customers will experience uninterrupted service and solid support worldwide. As both
companies operate warehouse and customer service facilities in the Chicago area, it’s
expected a smooth transition for the North American customers. Lipid Nutrition’s
manufacturing facility in the Netherlands will provide faster delivery to European clients and
supply international needs.
“This acquisition is a logical step for us, reaffirming Lipid Nutrition’s commitment to the
growth of the CLA market,” said Aat Visser, President of Lipid Nutrition. “CLA One® is a solid
brand, coupled with our extensive expertise and lipid knowledge, customers will benefit
significantly”. Lipid Nutrition holds a strong position. As one of the market leaders, Lipid
Nutrition is confident it will continue to grow and in the CLA market more specifically.
Clarinol™ and CLA One®
The integration of the Clarinol™ and CLA One® brands under one global supplier is beneficial
to all customers. Lipid Nutrition provides access to a wider CLA product portfolio (most
notably their Clarinol™ 95% CLA and highly concentrated Clarinol™ Powder), access to its
CLA patent portfolio, as well as access to the all-important WARF CLA patents covering
claims related to body composition. Lipid Nutrition’s dedicated CLA production facility, which
is the largest in the world, will also provide CLA One® customers assurance of the highest
quality and consistent product.
Lipid Nutrition is a division of Loders Croklaan
Dedicated to creating products that enhance wellness, PharmaNutrients supports
research investigating fatty acids and soluble fibers. Their activities encompass multiple
technology platforms focusing on creating solutions for obesity-related health issues
including weight management, inflammation, diabetes and cardiovascular health.
PharmaNutrients is a privately held company located in the Chicago area. Their
proprietary ingredients are used in a wide range of dietary supplements across the globe.
About Lipid Nutrition
Lipid Nutrition, a division of IOI-Loders Croklaan Group B.V., is a global leader in the
supply of scientifically sound lipid ingredients from natural origin, which improve and
maintain health and well-being.
PinnoThin™ is the latest ingredient (introduced in May 2005) and reduces appetite. Next
to weight management Lipid Nutrition offers a variety of branded products like Safflorin™
isomerized safflower oil for immune health, Marinol™ naturally concentrated fish oils for
heart health and brain development, Membranol™ phosphatidyl choline enriched lecithin
for liver health and memory improvement and Betapol™ human milk fat substitute for
Lipid Nutrition won several awards for their products. The International Society of
antioxidants in Nutrition and Health’ (ISANH) awarded Clarinol™ CLA as the Slimming
Ingredient for the year 2004/2005 and in December 2005 Lipid Nutrition won the Frost &
Sullivan’s 2005 Excellence in Technology Award in the field of nutraceuticals - nutritional
lipids. The Award recognises the company’s development of novel, natural-origin lipid
ingredients, particularly breakthrough products such as Betapol™, Clarinol™, Safflorin™,